company background image
BUDZ logo

WEED OTCPK:BUDZ Stock Report

Last Price

US$0.073

Market Cap

US$9.0m

7D

-6.4%

1Y

4.4%

Updated

26 Mar, 2024

Data

Company Financials

BUDZ Stock Overview

WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments.

BUDZ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

WEED, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for WEED
Historical stock prices
Current Share PriceUS$0.073
52 Week HighUS$0.15
52 Week LowUS$0.05
Beta0.94
1 Month Change-7.25%
3 Month Change7.49%
1 Year Change4.41%
3 Year Change-90.12%
5 Year Change-92.87%
Change since IPO-51.27%

Recent News & Updates

Recent updates

Shareholder Returns

BUDZUS PharmaceuticalsUS Market
7D-6.4%-0.2%0.6%
1Y4.4%23.9%29.5%

Return vs Industry: BUDZ underperformed the US Pharmaceuticals industry which returned 23.1% over the past year.

Return vs Market: BUDZ underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is BUDZ's price volatile compared to industry and market?
BUDZ volatility
BUDZ Average Weekly Movement12.7%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: BUDZ has not had significant price volatility in the past 3 months.

Volatility Over Time: BUDZ's weekly volatility has decreased from 19% to 13% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
19992Glenn Martinhttps://weedincusa.com

WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments. It is involved in the cultivation and harvesting cannabis and hemp for research, product development, processing, manufacturing, and sale of pharmaceutical and non-pharmaceutical products, services, therapeutics, and treatments for the medical applications. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015.

WEED, Inc. Fundamentals Summary

How do WEED's earnings and revenue compare to its market cap?
BUDZ fundamental statistics
Market capUS$8.95m
Earnings (TTM)-US$492.63k
Revenue (TTM)n/a

0.0x

P/S Ratio

-18.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BUDZ income statement (TTM)
RevenueUS$0
Cost of Revenue-US$2.23k
Gross ProfitUS$2.23k
Other ExpensesUS$494.86k
Earnings-US$492.63k

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.004
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio24.0%

How did BUDZ perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.